NO984616L - Anti-HIV preparat inneholdende et imidazolderivat - Google Patents

Anti-HIV preparat inneholdende et imidazolderivat

Info

Publication number
NO984616L
NO984616L NO984616A NO984616A NO984616L NO 984616 L NO984616 L NO 984616L NO 984616 A NO984616 A NO 984616A NO 984616 A NO984616 A NO 984616A NO 984616 L NO984616 L NO 984616L
Authority
NO
Norway
Prior art keywords
preparation containing
imidazole derivative
hiv preparation
hiv
imidazole
Prior art date
Application number
NO984616A
Other languages
English (en)
Norwegian (no)
Other versions
NO984616D0 (no
Inventor
Tamio Fujiwara
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26423589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO984616(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO984616D0 publication Critical patent/NO984616D0/no
Publication of NO984616L publication Critical patent/NO984616L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
NO984616A 1996-04-04 1998-10-02 Anti-HIV preparat inneholdende et imidazolderivat NO984616L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8256396 1996-04-04
JP8513296 1996-04-08
PCT/JP1997/000812 WO1997037657A1 (en) 1996-04-04 1997-03-14 Anti-hiv composition containing imidazole derivative

Publications (2)

Publication Number Publication Date
NO984616D0 NO984616D0 (no) 1998-10-02
NO984616L true NO984616L (no) 1998-11-26

Family

ID=26423589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984616A NO984616L (no) 1996-04-04 1998-10-02 Anti-HIV preparat inneholdende et imidazolderivat

Country Status (13)

Country Link
US (1) US6083958A (pt)
EP (1) EP0906756A4 (pt)
JP (1) JP3272369B2 (pt)
KR (1) KR100310888B1 (pt)
CN (1) CN1111406C (pt)
AU (1) AU712071B2 (pt)
BR (1) BR9708592A (pt)
CA (1) CA2250844C (pt)
MX (1) MXPA98008158A (pt)
NO (1) NO984616L (pt)
PL (1) PL187925B1 (pt)
TW (1) TW477701B (pt)
WO (1) WO1997037657A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9911457A (pt) * 1998-06-24 2001-12-11 Univ Emory Uso de 3'-azida-2', 3'-dideoxiuridina em combinaçãocom drogas anti-hiv adicionais para a manufaturade um medicamento para o tratamento de hiv
GB9909154D0 (en) * 1999-04-22 1999-06-16 Nippon Glaxo Limited Pharmaceutical formulation
HUP0301713A3 (en) * 2000-06-13 2005-04-28 Shionogi & Co Pharmaceutical compositions containing propenone derivatives and their use
WO2005016912A1 (en) * 2003-08-19 2005-02-24 Pfizer Inc. An efficient microbial preparation of capravirine metabolites m4 and m5

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2032259A1 (en) * 1989-12-18 1991-06-19 Wayne J. Thompson Hiv protease inhibitors useful for the treatment of aids
IL99843A0 (en) * 1990-11-01 1992-08-18 Merck & Co Inc Synergistic combination of hiv reverse transcriptase inhibitors
TW235963B (pt) * 1992-01-16 1994-12-11 Shionogi & Co
KR100387157B1 (ko) * 1994-09-26 2003-09-29 시오노기세이야쿠가부시키가이샤 이미다졸유도체

Also Published As

Publication number Publication date
MXPA98008158A (es) 2002-02-08
KR20000005115A (ko) 2000-01-25
CA2250844C (en) 2002-09-10
PL187925B1 (pl) 2004-11-30
EP0906756A1 (en) 1999-04-07
AU712071B2 (en) 1999-10-28
AU1940797A (en) 1997-10-29
US6083958A (en) 2000-07-04
CN1111406C (zh) 2003-06-18
CA2250844A1 (en) 1997-10-16
EP0906756A4 (en) 2000-11-22
WO1997037657A1 (en) 1997-10-16
JP3272369B2 (ja) 2002-04-08
CN1220604A (zh) 1999-06-23
NO984616D0 (no) 1998-10-02
KR100310888B1 (ko) 2001-12-12
PL329174A1 (en) 1999-03-15
BR9708592A (pt) 1999-08-03
TW477701B (en) 2002-03-01

Similar Documents

Publication Publication Date Title
FI971234L (fi) Imidatsolijohdannainen
BR9509805A (pt) Derivados de triazolila
DE69703385D1 (de) Alkoxyessigsäure-derivate
NO990821D0 (no) Arylsulfonylamino-hydroksaminsyre-derivater
EE9900211A (et) Asendatud pürasooliderivaadid
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
DE69613368D1 (de) Chinazolin derivate
DE69613369D1 (de) Chinazolin derivate
DE69613367D1 (de) Chinazolin derivate
DE69623574D1 (de) Statorring
NO982032D0 (no) Topisk preparat inneholdende capsazepin
DE59605795D1 (de) Triazolylmethyl-oxirane
NO986087D0 (no) Oralt preparat omfattende en antifungal triazolforbindelse
ITMI951395A0 (it) Formulazioni di f-silicone
ATE230734T1 (de) 3-alkoxyisoxazol-4-yl-substituierte 2- aminocarbonsäurederivate
EP0837863A4 (en) DISODIUM ALENDRONATE PREPARATIONS
EE03615B1 (et) Pürasool-4-üülhetaroüülderivaadid herbitsiididena
DE69623681D1 (de) Stromverstärker
ATE187165T1 (de) Benzophenonhydrazon-derivate als insektizide
NO984616L (no) Anti-HIV preparat inneholdende et imidazolderivat
NO950950D0 (no) Farmasöytisk preparat
NO991430D0 (no) Insektfordrivende formuleringer
NO961341D0 (no) Anordning for sikring av håndvåpen
ID16792A (id) Tatakan listrik insektisida
KR970003813U (ko) 농작물용 지지대